Fused cyclic compounds as GPR40 receptor modulators

The present invention provides a compound represented by the formula (I) : wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent...

Full description

Saved in:
Bibliographic Details
Main Authors YASUMA, TSUNEO, NEGORO, NOBUYUKI, ITOU, MASAHIRO, YAMASHITA, MASAYUKI
Format Patent
LanguageEnglish
French
German
Published 08.10.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound represented by the formula (I) : wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
Bibliography:Application Number: EP20130190005